Rapid COVID testing detecting presence of IgG and IgM to confirm antibody and/or active infection via finger prick blood sample. Result is available in less than 10 min. This test has a 7 to 14 day incubation latency from exposure time. If you have had recent exposure to a confirmed positive the nasal PCR test is recommended. https://www.diagnostic.grifols.com/en/assure-fastep-covid-19-igg-igm-rapid-test-kit/overview
The Care Start COVID 19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in a nasopharyngeal swab specimen directly collected from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset. Results are ready within 15 min of your test.
This test has an FDA Emergency Use Authorization, please refer to the manufacturers link below:
Status Covid 19/Flu test is a lateral flow immunoassay intended for the use in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS COV-2, Influenza A and Influenza B directly from the nasopharyngeal swab specimens obtained from individuals who are suspected of respiratory viral infection consistant with COVID 19. This test is recommended by the CDC to replace the PCR test due to its inability to determine Flu vs COVID.